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summary Atopic dermatitis (AD) is a chronic relapsing 
inflammatory skin disease with a distinctive clinical appear-
ance and distribution. Around 85% of patients have positive 
immediate skin reaction or specific IgE to different airborne 
allergens that are in association with respiratory allergy. The 
aim of this retrospective, open and uncontrolled study was to 
identify the most common inhalant allergens in AD patients, 
AD/allergic rhinitis patients, and AD/bronchial asthma pa-
tients by skin prick test per year during the 2001-2005 pe-
riod.
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INTrODuCTION
Atopic dermatitis (AD) is a chronic relapsing 
inflammatory skin disease with a distinctive clini-
cal appearance and distribution. AD is divided into 
“intrinsic” type that is non-IgE-associated, and 
“extrinsic” that is IgE-associated. Around 85% of 
patients have positive immediate skin reaction or 
specific IgE to different airborne allergens. AD can 
be “pure” AD or ”mixed AD”, i.e. in association with 
respiratory allergy. Additionally, an important role 
has been ascribed to cell mediated or delayed hy-
persensitivity with biphasic cytokine profile, initially 
Th2 and later on with Th2/Th1 cytokine pattern (1). 
The pathogenesis of AD is multifactorial and is 
the result of complex interaction among genetic, 
immune and environmental factors in combina-
tion with dietary and airborne allergens, infections, 
stress and decreased skin barrier (1-7). Genetic 
compound in the development of AD is high. In 
a cohort of 372 AD patients, 59% had respirato-
ry allergy and in 73% there was a positive fam-
ily history of atopy (3). The incidence of allergic 
asthma (79%) and allergic rhinitis (32%) was also 
high in families with AD but free from respiratory 
allergy (3).
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 Many allergens are considered to be trigger 
factors in AD patients (3). Food allergens are im-
portant in exacerbation of AD, mainly in the subset 
of young children, usually under age three, e.g., 
cow’s milk, egg, peanuts, soy, and wheat (8). Most 
food allergic children outgrow their food hypersen-
sitivity in the first few years of life, usually till the 
age of three, so food allergy is not a common trig-
ger factor in older patients with AD. 
Airborne allergens such as house dust mites 
(HDM), plant pollen allergens, moulds, animal-
derived allergens, and bacterial allergens may be 
responsible for exacerbations of skin inflammation 
and for atopic involvement of respiratory system 
(9). Skin lesions can develop after contact and in-
halation of aeroallergens. It seems to be of specific 
importance in both adults and children (5,6,9-11). 
Reactivity to allergens can be measured as spe-
cific serum IgE, positive skin prick test and posi-
tive atopy patch test (4).
PaTIENTs aND mETHODs
 aims
The purposes of this study were to identify 
the most common inhalant allergens in all three 
groups of patients by use of skin prick test. AD pa-
tients, AD/allergic rhinitis patients, and AD/bron-
chial asthma patients were examined each year 
from 2001 to 2005, and allergens were identified 
with an increased or decreased frequency in each 
group of patients.
 study design
It was a retrospective, open and uncontrolled 
study of 5-year duration (2001-2005).
 Patients 
A positive history of atopy, total IgE and clini-
cal diagnosis of AD, or AD with rhinitis or AD with 
bronchial asthma were recorded in 1097 patients. 
Skin prick testing was performed in 1097 patients 
(373 female and 724 male) at the Outpatient Al-
lergy Clinic, University Department of Dermatol-
ogy and Venereology, Zagreb University Hospital 
Center, Zagreb, Croatia, during the 2001-2005 
period. The study included patients with clinical 
diagnoses of AD, AD/allergic rhinitis, and AD/
bronchial asthma. The mean patient age was 36, 
range 3 to 74 years.   
Skin prick test (SPT) was performed according 
to the European Standard (ES) using commercial-
ly prepared solutions (supplied by the Institute of 
Immunology, Zagreb). The test was performed on 
clinically uninvolved skin on the subjects’ forearms 
(10,11). Early-phase reaction was read after 20-
30 minutes as maximum reaction is seen 15-20 
minutes after the allergen has been pricked to the 
epidermis. Positive histamine control was read at 
10-15 minutes. A wheal of >3 mm in diameter and/
or erythema were considered as positive reaction. 
Negative control with a buffer was performed in 
case when the wheals were of the same diameter. 
Patients were asked not to take drugs for allergy, 
sleeping, tranquilizers and analgesics for three 
days before skin prick testing. 
Total IgE was performed in all 1097 patients. 
Values of total IgE were determined by the stan-
dardized radioimmunosorbent test (RIST) or en-
zyme linked immunosorbent assay (ELISA). The 
upper normal IgE value was set at 150 IU/mL, and 
was age-adjusted in children (12).
We used Statistica 6.0 (StatSoft Inc., Chicago, 
USA) software package for Windows to perform 
statistical data analysis. Microsoft Office Excel 
2003 was used on data input and collection. Chi-
square test was used to estimate differences be-
tween categories of variables, and odds ratio with 
relative risks was used to calculate the probability 
of predictors. All statistical values were considered 
significant at p level of 0.005.
rEsuLTs 
A positive history of atopy and clinical diagno-
sis of AD, or AD with rhinitis or AD with bronchial 
asthma were recorded in 1097 patients, mean age 
36 (range 3 to 74) years. There were 863 (78.7%) 
AD patients, mean age 34 (range 3-58) years, all 
with a mild to moderate disease of variable dura-
tion. There were 182 (16.6%) patients with the di-
Result AD % AD/Rhinitis % AD/Bronchial asthma %
Normal 347 40.2     38 20.9   8 15.4
Very increased 516 59.8   144 79.1 44 84.6
Total 863 100.0   182 100.0 52 100.0
Table 1. Number of patients with increased values of total IgE by ELISA and RIST in patient groups with 
atopic dermatitis (AD) and two atopic diseases
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Inhalant allergen
                                   Total 2001-2005
Bronchial asthma (n) AD (n) Allergic rhinitis (n)
House dust mite 12 139 44
Dermatophagoides pteronyssinus 18 250 78
Feathers 3 28 12
Kermes oak 8 185 55
Timothy grass 9 188 52
Blue grass 0 4 0
Rye 8 166 50
Common hazel 10 88 41
White birch 11 83 45
Black pine 2 28 12
Acacia 4 20 20
Plane-tree 3 14 8
White poplar 1 22 12
Lime-tree 0 37 13
Olive 3 40 21
Elderberry 4 34 12
White willow 0 1 2
Oak 7 72 27
Ragweed 7 152 69
Mugwort 5 104 52
Lichwort 2 38 26
Dandelion 4 67 33
agnosis of AD/allergic rhinitis, mean age 43 (range 
5-74) years. There were 52 (4.7%) patients with 
AD/bronchial asthma, mean age 39 (range 3-68) 
years.
Increased values of IgE were found in 516 
(59.8%) AD, 144 (79.1%) AD/allergic rhinitis, and 
44 (84.6%) AD/bronchial asthma patients. In all 
three groups of patients, Dermatophagoides ptero-
nyssinus was the most common allergen, followed 
by timothy grass and kermes oak in AD group, 
ragweed and kermes oak in AD/rhinitis group, and 
house dust and white willow in AD/bronchial asth-
ma group (Table 2). Correlation of study groups 
with allergens in the 2001-2005 period is shown in 
Tables 3, 4 and 5.  
In AD group, the most common positive prick 
test was for Dermatophagoides pteronyssinus 
(26.70%, 27.85%, 26.17%, 30.1%, and 26.60%) 
and grass pollen (22.73%, 20.09%, 22.43%, 
24.06%, and 23.40%) (Table 3). In AD/allergic rhini-
tis group, the most common positive prick test was 
for Dermatophagoides pteronyssinus (20.83%, 
27.85%, 23.33%, 25%, and 18.52%) and weed 
pollen (25%, 23.42%, 16.67%, 25%, and 29.63%) 
(Table 4). In AD/bronchial asthma group, the most 
common positive prick test was for Dermatopha-
goides pteronyssinus (35%) in 2001, house dust 
mite (17.65%) and weed pollen in 2002, grass 
(50%) and weed pollen (50%) in 2003, and Der-
matophagoides pteronyssinus (33.33% and 40%, 
respectively) in 2004 and 2005 (Table 5).
Table 2. Inhalant allergens in three patient groups 2001-2005 
 2001 % 2002 % 2003 % 2004 % 2005 %
House dust mite 38 21.59 42 19.18 9 8.41 30 14.15 20 10.64
Dermatophagoides pteronyssinus 47 26.70 61 27.85 28 26.17 64 30.19 50 26.60
Feathers 5 2.84 14 6.39 3 2.80 3 1.42 7 3.72
Grass pollen 40 22.73 44 20.09 24 22.43 51 24.06 44 23.40
Tree pollen 17 9.66 23 10.50 20 18.69 25 11.79 27 14.36
Weed pollen 29 16.48 35 15.98 23 21.50 39 18.40 40 21.28
Table 3. Most common inhalant allergens in atopic dermatitis patients 2001-2005
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Approximately 20% of AD patients have low 
serum IgE levels and the lack of detectable envi-
ronmental allergen-specific serum IgE or positive 
skin prick test reactions (7,9). Johansson et al. 
report a relatively high proportion of AD patients 
without head and neck dermatitis and patients with 
low total serum IgE levels but positive atopy patch 
test for Malassezia sympodialis, despite lower 
proportions of individuals with Malassezia sympo-
dialis-specific IgE in these groups of patients (13). 
Although there is no explanation yet for the oc-
currence of positive atopy patch test without de-
tectable allergen-specific IgE, one could speculate 
about minute amounts of allergen-specific IgE not 
detected by skin prick test that are sufficient for 
antigen presentation (7). Moreover, Th-2 predomi-
nated type IV reaction initiated in the absence of 
specific IgE, or even a classic Th-1 predominated 
type IV reaction is thought to be responsible (7). 
In our study, concordance between a positive 
history of atopy, positive skin prick test for inhala-
tion allergens in AD patients with asthma and al-
lergic rhinitis was observed for dust mite, Dermat-
ophagoides pteronyssinus, grass pollen and weed 
pollen.
The prognosis of AD is usually good but the 
risk of developing asthma or allergic rhinitis is very 
high. Development of other symptoms or sensitiza-
tion is associated with a family history of eczema, 
age at onset of eczema and its severity, early ad-
verse reactions to foods, and proneness to infec-
tions (11). Pajno et al. conclude that assessment 
of sensitization to house dust mite by skin prick 
test is a marker for patients that are more likely to 
outgrow AD compared with those who will not (7). 
Most AD patients have elevated serum IgE 
(80%-85%) and skin prick test reactions to a wide 
variety of aeroallergens and food allergens (3,4). 
In our study, elevated total IgE was recorded in 
70% of AD patients. Moreover, the occurrence of 
IgE antibody to staphylococcal toxins, the yeast 
Candida albicans, opportunistic yeast Malassezia, 
and house dust mite suggest that microbial aller-
gens and house dust mite may be of importance 
in AD (3,5,6).  
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